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Introduction {#s1}
============

Exposure to ambient fine particulate matter (${PM}_{2.5}$) is associated with increased risk of cardiovascular morbidity and mortality ([@c2]). However, while the majority of inhaled ${PM}_{2.5}$ are known to deposit in the airway and not enter the systemic circulation ([@c56]), mechanisms that link ${PM}_{2.5}$ with cardiovascular effects remain elusive. The putative mechanisms for this include *a*) egress from the lung of ${PM}_{2.5}$ components, *b*) autonomic nervous system (ANS) dysfunction, and *c*) inflammation ([@c2]). Notably, despite that inhaled nanoparticles have been identified in remote organs, the pathophysiological role of these nanoparticles remain controversial, as their concentrations are low and inconsistent ([@c27]; [@c36]; [@c37]; [@c46]). ${PM}_{2.5}$ exposure is associated with decreased heart rate variability ([@c3]; [@c5]; [@c19]; [@c20]; [@c33]; [@c49]; [@c51]), indicating sympathetic nervous system (SNS) activation and/or parasympathetic nervous system withdrawal ([@c4]; [@c25]). However, because the nervous system can adapt to chronic stimulation, ANS dysfunction has been thought to play a trivial role in the mediation of the long-term health effects of ${PM}_{2.5}$ exposure ([@c2]). Evidence that cardiovascular effects of ${PM}_{2.5}$ are mediated by inflammation is stronger, given the established role of ${PM}_{2.5}$ in the of various cardiovascular diseases and evidence of inflammatory responses to ${PM}_{2.5}$ exposure in humans ([@c41]; [@c43]; [@c58]) and various animal models ([@c26]; [@c45]; [@c59]; [@c60]).

Putative effect mechanisms that involve ANS dysfunction or inflammation are not mutually exclusive, but may affect the same or different stages of pathogenesis, and may have synergistic effects ([@c2]). For example, ANS dysfunction may impact various inflammatory responses ([@c28]; [@c40]), and increases in circulating pro-inflammatory cytokines/mediators resulting from ${PM}_{2.5} - \text{related}$ pulmonary or systemic inflammation may cause ANS dysfunction ([@c12]; [@c55]; [@c69]). More importantly, there is emerging evidence that ANS dysfunction may also play a critical role in the long-term regulation of cardiovascular function ([@c10]; [@c16]; [@c48]), which appears to be dependent on an inflammatory response in the hypothalamus. For example, rats and mice fed a high-fat diet (HFD) showed rapid increases in hypothalamic inflammation, which may contribute to HFD feeding-induced long-term effects, including obesity and insulin resistance ([@c52]). Inhibition or deletion of IKK2 in some hypothalamic neurons was sufficient to abolish HFD feeding-induced ANS dysfunction, and subsequently, normalized blood pressure in a mouse model ([@c44]). Collectively, these data have highlighted a crucial role of an IKK2-dependent hypothalamic inflammatory response in the pathophysiology of various cardiovascular diseases.

The $\text{IKK}2/\text{NF} - \kappa B$ signaling pathway is pivotal in both acute and chronic inflammatory responses ([@c39]). Previous mechanistic studies by our laboratory ([@c24]; [@c62]) and others ([@c14]; [@c23]; [@c50]; [@c68]) have demonstrated that exposure to ambient ${PM}_{2.5}$ activates the $\text{IKK}2/\text{NF} - \kappa B$ pathway, which is believed to play a key role the pathophysiologic effects of ${PM}_{2.5}$ ([@c2]) in various tissues. Notably, we recently reported that chronic exposure of C57Bl/6J mice to ambient ${PM}_{2.5}$ resulted in activation of $\text{IKK}2/\text{NF} - \kappa B$ pathway in the hypothalamus, abnormal SNS activation, and hypertension ([@c65]), while in the KKay mouse model of type 2 diabetes, intracerebroventricular injection of an IKK2 inhibitor reduced ${PM}_{2.5}$ exposure--induced abnormalities in glucose homeostasis ([@c31]). These findings suggest that an IKK2-dependent hypothalamic inflammatory response may be crucial in the development of adverse health effects in response to ambient ${PM}_{2.5}$ exposure. In the present study, to verify the role of hypothalamic inflammation in the pathophysiologic effects of ambient ${PM}_{2.5}$, we exposed $\text{Nestin} - \text{creIKK}2^{\text{flox}/\text{flox}}$ ($\text{IKK}2^{\text{Neu} - \text{KO}}$) mice and littermate controls ($\text{Nestin} - \text{creIKK}2^{\text{flox}/ +}$) to filtered air (FA) or concentrated ambient ${PM}_{2.5}$ (CAP), and assessed their inflammatory and vascular responses.

Methods {#s2}
=======

Animals {#s2.1}
-------

University of Maryland, Baltimore (UMB) is an Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC)-accredited institution. All procedures of this study were approved by the Institutional Animal Care and Use Committee at UMB, and all the animals were treated humanely and with regard for alleviation of suffering. Nestin-cre transgenic mice in the C57Bl/6J background were obtained from Jackson Laboratories (Stock No.: 003,771). $\text{IKK}2^{\text{flox}/\text{flox}}$ mice were generated as previously described ([@c30]) and back-crossed with C57Bl/6J for three generations. $\text{Nestin} - \text{creIKK}2^{\text{flox}/\text{flox}}$ ($\text{IKK}2^{\text{Neu} - \text{KO}}$) and littermate $\text{Nestin} - \text{creIKK}2^{\text{flox}/ +}$ (control) mice were generated through in-house crossing of $\text{Nestin} - \text{creKK}2^{\text{flox}/ +}$ and $\text{IKK}2^{\text{flox}/\text{flox}}$. The pups were genotyped at the age of 1 wk by polymerase chain reaction (PCR), and the genotyping results were verified before exposure to FA/CAP.

Concentrated Ambient PM~2.5~ Exposure {#s2.2}
-------------------------------------

$\text{IKK}2^{\text{Neu} - \text{KO}}$ and control mice (male, 8--12 wk old) were grouped into four age-matched groups and randomly designated to be subjected to exposure to FA (six $\text{IKK}2^{\text{Neu} - \text{KO}}$ and seven controls) or CAP (seven $\text{IKK}2^{\text{Neu} - \text{KO}}$ and seven controls) from May 2016 to September 2016 for a total duration of 4 mo in a mobile trailer with a 12-h light/12-h dark cycle, temperatures of 18--25°C, and relative humidity of 40--60%. Because we failed to observe CAP exposure--induced impairment of glucose tolerance in female mice, male mice only were used in the present study. The mobile trailer was located on the campus of the UMB. Animal exposure and the monitoring of exposure atmosphere and ambient aerosol were performed as previously described using a versatile aerosol concentration enrichment system that was modified for long-term exposures ([@c18]; [@c32]). The exposure protocol comprised exposures for 6 h/d, 5 d/wk (no exposure took place during weekends). Ambient aerosol and exposure atmosphere were monitored as previously described ([@c32]). The elemental composition of CAP was determined by inductively coupled plasma mass spectroscopy (for trace element analysis as previously described ([@c35]; [@c62]).

Bronchoalveolar Lavage and Lung Histopathology {#s2.3}
----------------------------------------------

After euthanasia by overdose of isoflurane, the mouse trachea was cannulated, and the right primary bronchus was closed off with a ligature. Through the tracheal cannula, $0.5\;{mL}$ sterile phosphate-buffered saline with $0.1\,\text{mM}$ ethylenediaminetetraacetic acid (EDTA) was instilled and withdrawn to recover bronchoalveolar lavage fluid (BALF). This was repeated twice. The total number of cells in the collected BALF (around $1.5\;{mL}$) was estimated using a hemocytometer. Cytospin slides were prepared using Shandon Cytospin 3™ (Shandon) and stained with Diff-Quik solution (EMS). Differential cell counts for neutrophils, eosinophils, macrophages/monocytes, and lymphocytes were assessed by a pathologist who was blinded to the grouping.

Following BALF collection, the right lung was harvested. About one-third were cut and fixed with 4% paraformaldehyde, and the rest were snap frozen in liquid nitrogen and then kept at $- 80{^\circ}C$. To assess the inflammation in the lung, tissue blocks were embedded in paraffin, $5 - \mu m$-thick sections were cut, and the sections were subjected to hematoxylin and eosin staining. Three consecutive sections per sample were used for histopathology. Images covering all the tissue area were taken by a laboratory technician who was blinded to the grouping, and all images were then sent to and quantitated by the pathologist (blinded to the grouping, too).

Plasma Cytokine Analysis {#s2.4}
------------------------

To rapidly harvest blood samples for cytokine analysis, mouse retroorbital blood samples were collected in EDTA-treated tubes and subjected to centrifugation for 15 min at $2,000 \times \mathit{g}$ using a refrigerated centrifuge. The supernatants (plasma) were then transferred to new tubes and stored at $- 80{^\circ}C$ until assessments of cytokine levels. Plasma cytokine levels were assessed using BD™ Cytometric Bead Array Kit (BD Biosciences) per manufacturer's instructions. Briefly, $25\;\mu L/\text{mouse}$ plasma were incubated with the beads, and signaling was quantified by flow cytometry.

Real-Time Polymerase Chain Reactions {#s2.5}
------------------------------------

Mouse heads were removed before bronchoalveolar lavage. Hypothalamus, hippocampus, cortex, and olfactory bulb were immediately isolated. Epididymal adipose tissues were harvested after bronchoalveolar lavage. All these samples were snap frozen in liquid nitrogen and kept at $- 80{^\circ}C$. Total RNA was extracted and purified using the Trizol reagent (Invitrogen) from epididymal adipose tissue, lung, hypothalamus, hippocampus, cortex, and olfactory bulb. The quality of RNA was assessed by determination of the ratio of absorbance at $260\,\text{nm}$ to absorbance at $280\,\text{nm}$ by nanodrop. Two micrograms of total DNase-treated RNA were reverse transcribed into cDNA using High Capacity cDNA Reverse Transcription Kits (Applied Biosystems™) per manufacturer's instruction. Real-time PCR was performed using LightCycler® 480 SYBR Green I Master in the LightCycler® (Roche). Reactions were performed in a total volume of $10\;\mu L$ containing $1\;\mu L$ cDNA, $0.2\;\mu M$ of each primer, and $5\;\mu L$ of the SYBR® Green reaction mix. The ampliﬁcation protocol was as follows: $95{^\circ}C/5\,\text{min}$ ($95{^\circ}C/10\; s$, $60{^\circ}C/20\; s$, and $\left. 72{^\circ}C/30\; s \right) \times 45$. Following ampliﬁcation, a dissociation curve analysis was performed to ensure purity of PCR product. The speciﬁc sense and antisense primers for tumor necrosis factor-$\alpha$ $\left( \text{TNF}\alpha \right)$, interleukin (IL)-6, $\text{IL} - 1\beta$, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (the reference housekeeping gene) were previously described ([@c6]). In each sample, $2^{\Delta\Delta\text{Ct}}$ was calculated and used to represent its gene expression level.

Western Blotting {#s2.6}
----------------

Standard techniques were performed with primary antibodies: mouse Anti-IKK2 (Millipore), mouse $\text{Anti} - \beta - \text{Actin}$ (Sigma-Aldrich), and mouse Anti-GAPDH (Cell Signaling Technology). Signals were detected by chemiluminescence and analyzed by densitometry.

Vascular Function Assay {#s2.7}
-----------------------

After euthanasia, mouse thoracic aorta was quickly removed and cleaned in physiological salt solution (PSS) containing (mM): NaCl, 130; $\text{NaHCO}_{3}$, 14.9; KCl, 4.7; $\text{KH}_{2}\text{PO}_{4}$, 1.18; $\text{MgSO}_{4}$--$7H_{2}O$, 1.18; $\text{CaCl}_{2}$--$2H_{2}O$, 1.56; EDTA, 0.026; and glucose, 5.5. The aorta was cut into 2-mm rings. The aortic rings were then mounted in a muscle bath containing PSS at 37°C and bubbled with 95% $O_{2}$--5% $\text{CO}_{2}$. Isometric force generation was recorded with a Multi Myograph System (Danish Myo Technology). A resting tension of $4\,\text{mN}$ was imposed on each ring, and the rings were allowed to equilibrate for 1 h. To test vascular function, the contractile responses of aortic rings to phenylephrine (PE) in the absence or presence of an NOS inhibitor $\omega - \text{nitro} - L - \text{arginine}$ methyl ester (L-NAME; $100\,\mu M$) were assessed in an accumulative manner. To analyze the endothelial function, aortic rings were precontracted with PE ($1\;\mu M$), and acetylcholine (ACh) or sodium nitroprusside (SNP) was added in an accumulative manner.

Statistics {#s2.8}
----------

All data are expressed as $\text{means} \pm \text{standard\ errors\ of\ the\ mean}\,\left( \text{SEMs} \right)$ unless noted otherwise. Statistical tests were performed using one-way or two-way analysis of variance with Bonferroni post tests or unpaired *t*-tests using GraphPad Prism (version 4.1.2; GraphPad Software). The significance level was set at $p < 0.05$.

Results {#s3}
=======

Exposure Characterization {#s3.1}
-------------------------

The average ${PM}_{2.5}$ concentrations in the FA and CAP chambers were $3.6 \pm 1.9$ and $71.6 \pm 33.2{\,\mu g/m}^{3}$, respectively. [Table 1](#t1){ref-type="table"} shows the elemental composition of CAP and ambient ${PM}_{2.5}$. Although identifying ${PM}_{2.5}$ emission sources is generally beyond the scope of this paper, the relatively high ratio of Na/Al reflects more contribution by the marine source than the crustal source, which is consistent with the geographic proximity of the study site to the ocean ([@c21a]), whereas the relatively high sulfur suggests that the study site was most strongly affected by secondary aerosols, which are likely to include emissions from coal-fired utility boilers located regionally ([@c21a]).

###### 

Ambient particulate matter $\left( {PM} \right)_{2.5}$ and concentrated ambient ${PM}_{2.5}$ (CAP) in the exposure chambers were collected to Teflon filters weekly, and their elemental compositions were determined by inductively coupled plasma mass spectroscopy (ICP-MS).

Table 1 lists elements in the first column; the corresponding mean in nanograms per cubic meter and SD for CAP and mean in percentage and SD for ambient are listed in the other columns.

  Element   CAP      Ambient           
  --------- -------- --------- ------- ------
  Na        35.14    19.66     11.95   3.24
  Mg        8.62     4.81      2.87    0.48
  Al        25.93    12.67     2.56    2.41
  Si        78.53    39.39     8.53    5.76
  P         1.00     0.50      0.18    0.10
  S         249.91   183.42    48.31   6.90
  K         20.38    11.57     3.19    0.86
  Ca        39.30    19.86     5.40    1.86
  Ti        3.55     2.09      0.59    0.14
  V         0.26     0.15      0.03    0.04
  Cr        0.28     0.15      0.07    0.02
  Mn        1.19     0.75      0.21    0.03
  Fe        47.19    30.10     7.92    0.84
  Ni        0.65     0.40      0.11    0.05
  Cu        1.45     0.93      0.36    0.10
  Zn        13.77    6.82      2.63    1.41
  As        0.19     0.10      0.03    0.02
  Se        0.13     0.06      0.01    0.02
  Br        8.42     5.22      1.42    0.35
  Sr        0.24     0.13      0.18    0.05
  Ag        0.55     0.19      0.06    0.13
  Sn        1.25     0.53      0.19    0.16
  Ba        1.66     1.16      0.32    0.23
  Ce        0.24     0.25      0.04    0.08
  Pr        0.30     0.13      0.04    0.06
  Er        0.98     0.75      0.20    0.06
  Lu        1.33     1.19      0.32    0.12
  W         0.41     0.26      0.12    0.08
  Ir        0.11     0.04      0.01    0.02
  Pt        0.20     0.09      0.02    0.03
  Au        0.22     0.14      0.03    0.03
  Hg        0.34     0.05      0.07    0.04
  Tl        0.11     0.04      0.01    0.02
  Pb        0.93     0.32      0.14    0.04

Note: CAP, concentrated ambient particulate matter $\left( {PM} \right)_{2.5}$; SD, standard deviation.

Characterization of $\mathbf{IKK}2^{{Neu} - \textit{\textbf{KO}}}$ and Evaluation of Pro-Inflammatory Cytokines after Exposure to Filtered Air or Concentrated Ambient $\mathbf{PM}_{2.5}$ {#s3.2}
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

In order to examine the role of neural inflammation in the ${PM}_{2.5}$ exposure--related pathophysiology, we generated $\text{Nestin} - \text{creIKK}2^{\text{flox}/\text{flox}}$ ($\text{IKK}2^{\text{Neu} - \text{KO}}$) and littermate $\text{Nestin} - \text{creIKK}2^{\text{flox}/ +}$ (control). Except for lower body weight at 12 wk of age (mean $22.3 \pm 1.1$ vs. $20.3 \pm 0.6\; g$ for controls and $\text{IKK}2^{\text{Neu} - \text{KO}}$, respectively, $n = 8/\text{group}$, student's *t*-test $p < 0.05$), adult $\text{IKK}2^{\text{Neu} - \text{KO}}$ mice were similar in appearance to adult control mice. [Figure 1A](#f1){ref-type="fig"} shows the deletion of IKK2 in the brain of $\text{IKK}2^{\text{Neu} - \text{KO}}$. To confirm the tissue-specific deletion of IKK2 in $\text{IKK}2^{\text{Neu} - \text{KO}}$, we assessed IKK2 protein levels in different tissues. [Figures 1B and C](#f1){ref-type="fig"} reveal that compared to control, $\text{IKK}2^{\text{Neu} - \text{KO}}$ had significantly decreased expression of IKK2 in the brain but not lung, heart, and epididymal adipose tissue, corroborating the neuron-specific deletion of IKK2 in these mice. Consistent with our previous study ([@c65]), [Figures 1D and E](#f1){ref-type="fig"} show that CAP exposure significantly increased the hypothalamic expression of $\text{TNF}\alpha$ and IL-6 mRNAs. Neural IKK2 knockout did not significantly alter the hypothalamic expression levels of $\text{TNF}\alpha$ and IL-6 mRNAs in FA-exposed mice, but significantly reduced them in CAP-exposed mice. Given that recent studies have suggested that some components of ambient ${PM}_{2.5}$ may enter the brain through the olfactory system ([@c34]), we isolated olfactory bulb, cortex, and hippocampus, and assessed their expression of $\text{TNF}\alpha$ and IL-6 mRNAs. Except for a marked trend of increase in the expression of IL-6 mRNA in the hippocampus of CAP-exposed control mice vs. that of FA-exposed control mice, no any other remarkable difference was observed ([Figures 1F--K](#f1){ref-type="fig"}).

![Tissue-specific IKK2 expression and brain region--specific higher tumor necrosis factor-$\alpha$ $\left( \text{TNF}\alpha \right)$ and interleukin (IL)-6 mRNA expression. (*A*) Polymerase chain reaction (PCR) assay of flox allele (F), wild-type allele (W), and deletion allele (D) according to genotype in 13-wk-old male mice. Lane 1: $\text{IKK}2^{\text{flox}/ +}$; Lane 2, $\text{Nestin} - \text{creIKK}2^{+ / +}$; Lanes 3--5, $\text{Nestin} - \text{creIKK}2^{\text{flox}/\text{flox}}$ ($\text{IKK}2^{\text{Neu} - \text{KO}}$); Lanes 6--8, $\text{Nestin} - \text{creIKK}2^{\text{flox}/ +}$ (control); Lane 9, marker. (*B*--*C*) Representative Western blot (B) and $\text{mean} \pm \text{standard}\,\text{deviation}\,\left( \text{SD} \right)$ IKK2 protein expression in brain, fat, lung, and heart tissues from male control ($n = 8$) and $\text{IKK}2^{\text{Neu} - \text{KO}}$ ($n = 7$) mice at 10--16 wk of age. \*$p < 0.05$ vs. control, one-way analysis of variance (ANOVA). (*D*--*K*) $\text{TNF}\alpha$ and IL-6 mRNA expression in hypothalamus, hippocampus, cortex, and olfactory bulb tissues harvested from control and $\text{IKK}2^{\text{Neu} - \text{KO}}$ mice ($n = 6 - 7/\text{group}$) at 8--12 wk of age following 4 mo of exposure to concentrated ambient particulate matter $\left( {PM} \right)_{2.5}$ (CAP) or filtered air (FA). \*$p < 0.05$ vs. FA, ^\#^$p < 0.05$ vs. control, ANOVA.](EHP2311_f1){#f1}

Evaluation of Pulmonary Inflammation after Exposure to Filtered Air or Concentrated Ambient $\mathbf{PM}_{2.5}$ {#s3.3}
---------------------------------------------------------------------------------------------------------------

Central inflammation has been implicated in the regulation of peripheral inflammatory responses ([@c31]), and pulmonary inflammation is widely believed to be essential in the pathophysiology due to exposure to ambient ${PM}_{2.5}$ ([@c2]). To determine whether central inflammation plays a role in the inflammatory response of the lung to ${PM}_{2.5}$ inhalation, we performed BALF cell differentiation. [Figures 2A--D](#f2){ref-type="fig"} reveal that exposure to CAP significantly increased BALF total cells and macrophages in control mice. Consistent with many previous studies ([@c15]; [@c67]), although neutrophil infiltration is the hallmark of inflammation, we did not observe significant increase in BALF neutrophils in CAP-exposed mice ([Figure 2D](#f2){ref-type="fig"}). This may be a reflection of the crucial role of neutrophils in acute but not chronic inflammatory response. BALF cell numbers were not significantly different between CAP- vs. FA-exposed neural IKK2--deficient mice, which suggests that CAP exposure--induced pulmonary inflammation may be regulated by a central mechanism. To confirm this, we performed lung histological analysis. The percentage of alveolar macrophages was significantly higher in CAP-exposed vs. FA-exposed $\text{IKK}2^{\text{Neu} - \text{KO}}$ mice and control mice, but was significantly lower in CAP-exposed $\text{IKK}2^{\text{Neu} - \text{KO}}$ mice vs. CAP-exposed controls ([Figure 2E--F](#f2){ref-type="fig"}). Pulmonary $\text{TNF}\alpha$ and IL-6 expression was higher in CAP-exposed vs. FA mice, though the difference was significant only for controls ([Figure 2G--I](#f2){ref-type="fig"}). In addition, pulmonary IL-6 mRNA expression was significantly lower in CAP-exposed $\text{IKK}2^{\text{Neu} - \text{KO}}$ mice than in CAP-exposed controls ([Figure 2H](#f2){ref-type="fig"}).

![Markers of pulmonary inflammation after 4 mo of exposure to concentrated ambient particulate matter $\left( {PM} \right)_{2.5}$ (CAP) or filtered air (FA) in male $\text{Nestin} - \text{creIKK}2^{\text{flox}/ +}$ control and $\text{Nestin} - \text{creIKK}2^{\text{flox}/\text{flox}}$ ($\text{IKK}2^{\text{Neu} - \text{KO}}$) mice ($n = 6 - 7/\text{group}$). (*A*--*D*) Total cells, macrophages, lymphocyte, and neutrophil cell counts \[$\text{means} \pm \text{standard}\,\text{deviation}\,\left( \text{SD} \right)$\] in bronchoalveolar lavage fluid (BALF). (*E*--*F*) Representative histologic sections (red arrows indicate macrophages), and $\text{means} \pm \text{SD}$ % alveolar macrophages, respectively, according to exposure and genotype ($\text{scale}\,\text{bar} = 50\;\mu m$). (*G*--*I*) Tumor necrosis factor-$\alpha$ $\left( \text{TNF}\alpha \right)$, interleukin (IL)-6, and $\text{IL} - 1\beta$ mRNA expression in pulmonary tissue samples according to exposure and genotype ($\text{means} \pm \text{SD}$). \*$p < 0.05$ vs. FA, ^\#^$p < 0.05$ vs. control, analysis of variance (ANOVA).](EHP2311_f2){#f2}

Evaluation of Systemic and Adipose Inflammation after Exposure to Filtered Air or Concentrated Ambient $\mathbf{PM}_{2.5}$ {#s3.4}
--------------------------------------------------------------------------------------------------------------------------

Systemic inflammation is one of the putative mechanisms that mediate the development of extrapulmonary abnormalities due to exposure to ambient ${PM}_{2.5}$ ([@c2]). In control mice, CAP vs. FA exposure was associated with higher plasma $\text{TNF}\alpha$, $\text{IL} - 1\beta$, and IL-6 levels (significant for $\text{IL} - 1\beta$ and IL-6 only) ([Figure 3A--C](#f3){ref-type="fig"}). In CAP-exposed $\text{IKK}2^{\text{Neu} - \text{KO}}$ mice, plasma $\text{TNF}\alpha$, $\text{IL} - 1\beta$, and IL-6 were lower than in CAP-exposed controls (significant for $\text{TNF}\alpha$ and $\text{IL} - 1\beta$ only). In addition, IL-6 was significantly higher in CAP- vs. FA-exposed $\text{IKK}2^{\text{Neu} - \text{KO}}$ mice. ([Figure 3C](#f3){ref-type="fig"}). In addition, exposure to ambient ${PM}_{2.5}$ has been shown to induce marked inflammation in adipose tissues, and the latter is believed to be subsequent to systemic inflammation and play a role in the ${PM}_{2.5}$ exposure--related abnormalities in energy and glucose metabolism ([@c2]). CAP vs. FA exposure was associated with significantly higher $\text{IL} - 1\beta$ mRNA expression in epididymal adipose tissue from both $\text{IKK}2^{\text{Neu} - \text{KO}}$ and control mice, but was not associated with significant differences in $\text{TNF}\alpha$ or IL-6 expression ([Figure 4A--C](#f4){ref-type="fig"}). $\text{IL} - 1\beta$ mRNA expression in adipose tissue was significantly lower in FA-exposed $\text{IKK}2^{\text{Neu} - \text{KO}}$ mice vs. FA controls and in CAP-exposed $\text{IKK}2^{\text{Neu} - \text{KO}}$ mice vs. CAP controls ([Figure 4C](#f4){ref-type="fig"}). Macrophage infiltration in epididymal adipose tissue was significantly higher in CAP-exposed $\text{IKK}2^{\text{Neu} - \text{KO}}$ and control mice relative to FA-exposed $\text{IKK}2^{\text{Neu} - \text{KO}}$ and control mice, respectively, but was significantly lower in CAP-exposed $\text{IKK}2^{\text{Neu} - \text{KO}}$ mice than in CAP-exposed controls ([Figure 4D--E](#f4){ref-type="fig"}).

![Plasma cytokine levels (BD™ Cytometric Bead Array Kit) following 4 wk of concentrated ambient particulate matter $\left( {PM} \right)_{2.5}$ (CAP) or filtered air (FA) exposure in male $\text{Nestin} - \text{creIKK}2^{\text{flox}/ +}$ control and $\text{Nestin} - \text{creIKK}2^{\text{flox}/\text{flox}}$ ($\text{IKK}2^{\text{Neu} - \text{KO}}$) mice at 8--12 wk of age ($n = 6–7/\text{group}$). (*A*) Tumor necrosis factor-$\alpha$ $\left( \text{TNF}\alpha \right)$, (*B*) interleukin $\left( \text{IL} \right) - 1\beta$, (*C*) IL-6. \*$p < 0.05$ vs. FA, ^\#^$p < 0.05$ vs. control, analysis of variance (ANOVA).](EHP2311_f3){#f3}

![Cytokine mRNA expression in epididymal adipose tissue samples following 4 wk of filtered air (FA) or concentrated ambient particulate matter $\left( {PM} \right)_{2.5}$ (CAP) exposure in male $\text{Nestin} - \text{creIKK}2^{\text{flox}/ +}$ control and $\text{Nestin} - \text{creIKK}2^{\text{flox}/\text{flox}}$ ($\text{IKK}2^{\text{Neu} - \text{KO}}$) mice at 8--12 wk of age ($n = 6–7/\text{group}$). (*A*--*C*) Fold difference in mRNA \[quantitative real-time polymerase chain reaction (qPCR), relative to control gene\] of tumor necrosis factor-$\alpha$ $\left( \text{TNF}\alpha \right)$, interleukin (IL)-6, and $\text{IL} - 1\beta$, respectively, according to exposure and genotype \[$\text{mean} \pm \text{standard}\,\text{deviation}\,\left( \text{SD} \right)$\]. (*D*) Macrophage infiltration (number/500 adipocytes) according to exposure and genotype ($\text{mean} \pm \text{SD}$). (*E*) Representative histologic sections, scale bar, $25\;\mu m$. \*$p < 0.05$ vs. FA, ^\#^$p < 0.05$ vs. control, analysis of variance (ANOVA).](EHP2311_f4){#f4}

Evaluation of Endothelial Dysfunction after Exposure to Filtered Air or Concentrated Ambient $\mathbf{PM}_{2.5}$ {#s3.5}
----------------------------------------------------------------------------------------------------------------

Endothelial dysfunction may contribute to ${PM}_{2.5}$ exposure--related cardiometabolic abnormalities, such as insulin resistance and hypertension ([@c2]). CAP vs. FA exposure was associated with a significantly higher aortic contractile response to PE in both $\text{IKK}2^{\text{Neu} - \text{KO}}$ and control mice, though the maximal PE response was significantly lower in CAP-exposed $\text{IKK}2^{\text{Neu} - \text{KO}}$ mice than in CAP-exposed controls ([Figure 5A](#f5){ref-type="fig"} and [Table 2](#t2){ref-type="table"}). As increased contractile response may result from increased contractility of vascular smooth muscle and/or decreased endothelium-dependent relaxation, we next assessed the aortic response to an endothelium-dependent vasodilator, Ach. CAP vs. FA exposure was associated with a significantly reduced Ach-induced aortic relaxation in both $\text{IKK}2^{\text{Neu} - \text{KO}}$ and control mice, though the maximal effect was significantly lower in CAP-exposed $\text{IKK}2^{\text{Neu} - \text{KO}}$ mice than in CAP-exposed controls ([Figure 5B](#f5){ref-type="fig"} and [Table 2](#t2){ref-type="table"}). In contrast, we did not observe any significant effect of CAP exposure and neural IKK2 knockout on aortic contractile response to PE in the presence of a NOS inhibitor L-NAME ([Figure 5C](#f5){ref-type="fig"}) and aortic relaxation by endothelium-independent vasodilator SNP ([Figure 5D](#f5){ref-type="fig"}). Together, these findings support a role of central inflammation in the mediation of ambient ${PM}_{2.5}$ exposure--induced endothelial dysfunction.

![Endothelial function following 4 wk of filtered air (FA) or concentrated ambient particulate matter $\left( {PM} \right)_{2.5}$ (CAP) exposure in male $\text{Nestin} - \text{creIKK}2^{\text{flox}/ +}$ control and $\text{Nestin} - \text{creIKK}2^{\text{flox}/\text{flox}}$ ($\text{IKK}2^{\text{Neu} - \text{KO}}$) mice at 8--12 wk of age ($n = 6–7/\text{group}$). After sacrifice, aorta was immediately isolated and mounted onto myograph. (*A*) Aortic contractile response to phenylephrine (PE). (*B*) Aortic rings precontracted by PE ($1\;\mu M$) and then relaxed by acetylcholine (Ach). (*C*) Aortic contractile response to PE in the presence of the NOS inhibitor, L-NAME ($100\;\mu M$). (*D*) Aortic rings precontracted by PE ($1\;\mu M$) and then relaxed by the NO donor, sodium nitroprusside (SNP). Values are $\text{means} \pm \text{standard}\,\text{deviation}\,\left( \text{SD} \right)$. Numeric data for the maximum values are shown in [Table 2](#t2){ref-type="table"}.](EHP2311_f5){#f5}

###### 

Maximal effects and logEC50s \[$\text{means} \pm \text{standard}\,\text{deviation}\,\left( \text{SD} \right)\rbrack$ from myograph analyses of endothelial function following 4 mo of filtered air (FA) or concentrated ambient particulate matter $\left( {PM} \right)_{2.5}$ (CAP) exposure in male $\text{Nestin} - \text{creIKK}2^{\text{flox}/ +}$ (control) and $\text{Nestin} - \text{creIKK}2^{\text{flox}/\text{flox}}$ ($\text{IKK}2^{\text{Neu} - \text{KO}}$) mice at 8--12 weeks of age ($n = 6–7/\text{group}$).

Table 2 lists experiments in the first column; the corresponding values for FA virgule control, CAP virgule control, FA virgule IKK2 super Neu KO, and CAP virgule IKK2 super Neu KO are listed in the other columns.

  Experiment        FA/control        CAP/control                                        $\text{FA/IKK}2^{\text{Neu} - \text{KO}}$   $\text{CAP/IKK}2^{\text{Neu} - \text{KO}}$
  ----------------- ----------------- -------------------------------------------------- ------------------------------------------- ------------------------------------------------------------------------------------
  PE                                                                                                                                  
   Maximal effect   $53 \pm 3$        $81.8 \pm 4.2$[^\*^](#t2n2){ref-type="table-fn"}   $58.1 \pm 6.1$                              $69 \pm 3.3$[^\*^](#t2n2){ref-type="table-fn"}[^\#^](#t2n3){ref-type="table-fn"}
   logEC50          $- 7.5 \pm 0.2$   $- 7.6 \pm 0.2$                                    $- 7.3 \pm 0.3$                             $- 7.3 \pm 0.3$
  Ach                                                                                                                                 
   Maximal effect   $49.2 \pm 6.3$    $71.3 \pm 4.4$[^\*^](#t2n2){ref-type="table-fn"}   $45.5 \pm 8.1$                              $57.5 \pm 4.8$[^\*^](#t2n2){ref-type="table-fn"}[^\#^](#t2n2){ref-type="table-fn"}
   logEC50          $- 7 \pm 0.3$     $- 7.2 \pm 0.4$                                    $- 6.9 \pm 0.3$                             $- 7.3 \pm 0.4$
  L-NAME/PE                                                                                                                           
   Maximal effect   $84.1 \pm 5.4$    $88.3 \pm 9$                                       $86.5 \pm 7.8$                              $92.2 \pm 11.4$
   logEC50          $- 6.9 \pm 0.2$   $- 6.7 \pm 0.3$                                    $- 6.9 \pm 0.3$                             $- 6.8 \pm 0.3$
  SNP                                                                                                                                 
   Maximal effect   $5.3 \pm 7.4$     $11.3 \pm 7.1$                                     $7.8 \pm 3.2$                               $10.3 \pm 7.2$
   logEC50          $- 7 \pm 0.2$     $- 6.9 \pm 0.2$                                    $- 7.1 \pm 0.3$                             $- 6.9 \pm 0.2$

Note: Complete data are shown in [Figure 5](#f5){ref-type="fig"}. Ach, acetylcholine; CAP, concentrated ambient particulate matter $\left( {PM} \right)_{2.5}$; FA, filtered air; L-NAME, ${L - N}^{G} - \text{Nitroarginine}$ methyl ester; PE, phenylephrine; SNP, sodium nitroprusside.

$p < 0.05$ vs. FA.

$p < 0.05$ vs. control, analysis of variance (ANOVA).

Discussion {#s4}
==========

Findings from experimental studies of mice suggest that exposure to ambient ${PM}_{2.5}$ may induce central inflammation characterized by activation of the $\text{IKK}2/\text{NF} - \kappa B$ signaling pathway in the hypothalamus ([@c31]; [@c65]). However, to our knowledge, the role of central inflammation in pathophysiologic responses to ambient ${PM}_{2.5}$ exposure has not yet been systemically investigated. In the present study, we exploited a mouse model with reduced neuronal IKK2 expression to examine the role of central inflammation in ${PM}_{2.5}$ exposure--induced peripheral inflammation and endothelial dysfunction. The main findings from the present study are that neural IKK2 reduction appears to inhibit CAP exposure--induced increases in *a*) hypothalamic $\text{TNF}\alpha$ and IL-6 mRNA expression; *b*) pulmonary, systemic, and adipose tissue inflammatory responses; and *c*) endothelial dysfunction. These findings provide further support for a role of central inflammation in the development of adverse cardiometabolic responses to ambient ${PM}_{2.5}$ exposure.

Central inflammation, particularly in the hypothalamus, has been shown to play an important role in the pathogenesis of various cardiometabolic diseases such as obesity, hypertension, and diabetes ([@c21]). We previously reported that exposure to ambient ${PM}_{2.5}$ was associated with increased expression of pro-inflammatory cytokines and activation of IKK2 in the mouse hypothalamus ([@c65]). As in our previous study, we demonstrated that CAP exposure increased expression of pro-inflammatory cytokines in the hypothalamus. In addition, we demonstrated that these responses to CAP exposure were significantly inhibited or abolished in mice with reduced neural IKK2 expression. We found that, on average, IKK2 protein expression was only $31 \pm 12\%$ lower in the brains of $\text{IKK}2^{\text{Neu} - \text{KO}}$ mice compared with $\text{Nestin} - \text{creIKK}2^{\text{flox}/ +}$ controls, consistent with neuron-specific knockout by Nestin-cre ([@c54]) and the presence of cells other than neurons in brain, including astrocytes and microglia that may play a role in local inflammatory responses ([@c11]; [@c22]). Nonetheless, the partial reduction in brain IKK2 expression appeared to be sufficient to reduce or eliminate CAP exposure--induced expression of $\text{TNF}\alpha$ and IL-6 mRNA in the hypothalamus. A recent study reported hypothalamic inflammation induced by a single-day exposure to an HFD was inhibited in vagotomized mice, suggesting that the vagal afferent nerve may be responsible for transmitting gut-derived inflammatory signals to the hypothalamus ([@c61]). Further studies are needed to determine whether a similar mechanism might be involved in CAP-induced hypothalamic inflammation.

In addition to systemic circulation, foreign materials may also gain access to the brain via the olfactory mucosa, known as olfactory bulb transmission ([@c53]). Given the previous demonstration of ambient particles in the brain ([@c34]) and increasing evidence that exposure to ambient ${PM}_{2.5}$ correlates to various brain insults ([@c57]), olfactory bulb transmission has been suspected to be an important mechanism for the access of ambient ${PM}_{2.5}$ to the brain ([@c57]). In the present study, CAP vs. FA exposure was associated with significantly higher expression of the pro-inflammatory cytokines $\text{TNF}\alpha$ and IL-6 in the hypothalamus, whereas in the olfactory bulb, $\text{TNF}\alpha$ expression was higher in CAP- vs. FA-exposed control mice, but not significantly, and there was a nonsignificant decrease in IL-6 expression. Additional research is needed to clarify the potential for olfactory bulb transmission of ${PM}_{2.5}$ to the brain, and its influence, if any, on central inflammation.

Another finding from the present study was that increases in plasma $\text{TNF}\alpha$, $\text{IL} - 1\beta$, and IL-6 in CAP- vs. FA-exposed control mice were reduced or eliminated in $\text{IKK}2^{\text{Neu} - \text{KO}}$ mice. This suggests a potential role of the central nervous system in inflammatory responses to CAP, consistent with our previous finding that intracerebrovascular administration of an IKK2 inhibitor was associated with reduced systemic inflammatory responses to CAP exposure ([@c31]). Moreover, as hypothalamic inflammation has been shown to correlate to ANS dysfunction ([@c21]), these present data are also consistent with increasing evidence that ANS regulates systemic inflammatory responses ([@c28]; [@c40]). Our finding that CAP exposure--induced pulmonary inflammation was reduced in $\text{IKK}2^{\text{Neu} - \text{KO}}$ mice compared with controls ([Figure 2](#f2){ref-type="fig"}), consistent with involvement of a central neural mechanism in pathophysiologic responses to ${PM}_{2.5}$ exposure, may seem inconsistent with compelling evidence that pulmonary inflammation in response to ambient ${PM}_{2.5}$ is induced through toll-like receptors (TLRs)- and/or pattern recognition receptors (PRRs)-dependent mechanisms ([@c1]; [@c17]; [@c47]; [@c70]). However, previous studies have also reported evidence of close cross-talk between the brain and lung ([@c9]; [@c13]; [@c64]).

Exposure to ambient ${PM}_{2.5}$ has been associated with endothelial dysfunction in humans ([@c38]; [@c63]) and various animal models ([@c8]; [@c29]; [@c66]), and effects of ${PM}_{2.5}$ on endothelial function have been implicated in the pathogenesis of cardiometabolic diseases associated with ${PM}_{2.5}$ exposure, such as atherosclerosis, hypertension, and type 2 diabetes mellitus ([@c7]). As such, endothelial dysfunction is widely believed to be central in the pathophysiology due to exposure to ${PM}_{2.5}$ ([@c2]). In the present study, although CAP exposure was associated with evidence of endothelial dysfunction in both control and $\text{IKK}2^{\text{Neu} - \text{KO}}$ mice, the response was significantly less pronounced in the mice with reduced neural IKK2 expression compared with controls, consistent with a role of central inflammation in ${PM}_{2.5}$ exposure--related effects. Many studies have demonstrated that systemic inflammation may lead to endothelial dysfunction ([@c42]).

Although the present study supports a role of neural IKK2 in pathophysiologic responses to ambient ${PM}_{2.5}$ exposure, it has a number of important limitations. These include the fact that we did not evaluate whether specific types of neurons, or neurons in specific locations, are responsible for differences in responses to CAPs between control and $\text{IKK}2^{\text{Neu} - \text{KO}}$ mice. This will require additional experiments targeting different neurons, particularly pro-opiomelanocortin and agouti-related peptide neurons in the hypothalamus and those in the nucleus ambiguus and dorsal nucleus of the brainstem, and concomitantly measuring effects of exposure to CAP. In addition, we did not investigate specific mechanisms through which neural IKK2 might mediate systemic inflammation or other effects of ${PM}_{2.5}$ exposure, or directly assess neural mechanisms linking ambient ${PM}_{2.5}$ with central inflammation.

Conclusion {#s5}
==========

In summary, our findings support a role of neural IKK2 in CAP exposure--induced local and systemic pro-inflammatory cytokine expression, pulmonary and adipose inflammation, and endothelial dysfunction, and thus advance knowledge our understanding of the contribution of central inflammation to the pathophysiologic effects of ambient ${PM}_{2.5}$ exposure.
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